RSS

Antimicrobial Discovery Solutions (ADS)

The Medicines Discovery Catapult, a new, national centre of applied research and development expertise, has revealed it is supporting a new ‘double-blind’ partnership to enable antimicrobial resistance (AMR) research. more

News